Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Applied Genetic Technologies Corp (AGTC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12098
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pigmentosa, alpha-1 antitrypsin deficiency and macular degeneration, among others. AGTC’s achromatopsia provides treatment inherited conditions that are associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and total loss of color discrimination. The company’s x-linked retinoschisis offers treatment in retinal degeneration affecting young males, presenting with poor vision by school age. It also offers ophthalmology development programs and proof-of-concept data in multiple indications. The company operates through its offices in Alachua and Cambridge, the US, and others. AGTC is headquartered in Alachua, Florida, the US.

Applied Genetic Technologies Corp (AGTC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Applied Genetic Technologies Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Applied Genetic Technologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Applied Genetic Technologies Corp, Medical Equipment, Deal Details 10
Partnerships 10
Applied Genetic Tech Enters into R&D Agreement with Bionic Sight 10
Equity Offering 11
Applied Genetic Tech Plans to Raise up to USD125 Million in Public Offering of Securities 11
Acquisition 13
Applied Genetic Acquires 5% Stake in Bionic Sight for USD2 Million 13
Applied Genetic Technologies Corp – Key Competitors 14
Applied Genetic Technologies Corp – Key Employees 15
Applied Genetic Technologies Corp – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
Sep 10, 2018: AGTC announces financial results and business update for the fourth quarter and fiscal year ended June 30, 2018 17
May 08, 2018: AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2018 19
Feb 09, 2018: AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017 21
Sep 13, 2017: AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2017 23
May 10, 2017: AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2017 25
Feb 08, 2017: AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2016 28
Corporate Communications 30
Sep 24, 2018: AGTC names William Aliski to its board of directors 30
Jun 14, 2018: AGTC Announces Expansion of Clinical and Regulatory Leadership Teams 31
Feb 14, 2018: AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization’s Board of Directors 32
Sep 05, 2017: AGTC Appoints Matthew Feinsod, M.D. as Interim Chief Medical Officer 33
Aug 02, 2017: AGTC Appoints William Sullivan as Chief Financial Officer, Andrew Ashe Named General Counsel 34
Product News 35
Aug 08, 2017: AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 16, 2017 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Applied Genetic Technologies Corp, Medical Equipment, Key Facts, 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Applied Genetic Technologies Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Deals By Market, 2012 to YTD 2018 8
Applied Genetic Technologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Applied Genetic Tech Enters into R&D Agreement with Bionic Sight 10
Applied Genetic Tech Plans to Raise up to USD125 Million in Public Offering of Securities 11
Applied Genetic Acquires 5% Stake in Bionic Sight for USD2 Million 13
Applied Genetic Technologies Corp, Key Competitors 14
Applied Genetic Technologies Corp, Key Employees 15

List of Figures
Applied Genetic Technologies Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Applied Genetic Technologies Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dairygold Co-operative Society Ltd:企業の戦略的SWOT分析
    Dairygold Co-operative Society Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Natera Inc (NTRA):医療機器:M&Aディール及び事業提携情報
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Hanwha Life Insurance Co Ltd:企業の戦略・SWOT・財務分析
    Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • GlycoNex Inc (4168)-製薬・医療分野:企業M&A・提携分析
    Summary GlycoNex Inc (GlycoNex) is a drug discovery company that conducts research and development in glycosphingolipid antigen and human monoclonal antibody technologies to develop cancer drugs. The company carries out antibody drug development through various technology platforms such as glycosphi …
  • International Paper Co:企業の戦略・SWOT・財務情報
    International Paper Co - Strategy, SWOT and Corporate Finance Report Summary International Paper Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • UIL Energy Ltd (UIL):石油・ガス:M&Aディール及び事業提携情報
    Summary UIL Energy Ltd (UIL Energy) is an oil and gas company. The company provides business activities such as exploration for reserves of both conventional and unconventional oil and natural gas plays in proven hydrocarbon basins in Western Australia. It offers portfolio such as gas and liquids th …
  • Sinovac Biotech Ltd (SVA):企業の財務・戦略的SWOT分析
    Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, bilive, anflu, panflu and panflu, among others. Its healive is an inactivated hepatitis A vaccine. Sinovac Biotech’s bilive i …
  • Mitsui Mining & Smelting Co Ltd:企業の戦略・SWOT・財務分析
    Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Southwestern Energy Company:企業の戦略・SWOT・財務情報
    Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report Summary Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Oil and Natural Gas Corp Ltd (ONGC):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil and Natural Gas Corp Ltd (ONGC) is an integrated energy company, operating along the hydrocarbon value chain. It discovers, produces, refines and markets oil and gas, and also manufactures petrochemicals. The company also conducts power generation and has considerable renewable energy op …
  • Chiyoda Corporation (6366)-石油・ガス分野:企業M&A・提携分析
    Summary Chiyoda Corporation (Chiyoda) is an engineering services provider that offers various services along with its subsidiaries. Its offerings include project management, program management, feasibility studies, front end engineering design works, engineering, procurement, construction, commissio …
  • Yamana Gold Inc.:企業のM&A・事業提携・投資動向
    Yamana Gold Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Yamana Gold Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Intellect Design Arena Limited:企業の戦略・SWOT・財務分析
    Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report Summary Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Greif Inc (GEF):企業の財務・戦略的SWOT分析
    Greif Inc (GEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Biogen, Inc.:戦略・SWOT・企業財務分析
    Biogen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Biogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Majestic Wine plc (WINE):企業の財務・戦略的SWOT分析
    Majestic Wine plc (WINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Selventa Inc-製薬・医療分野:企業M&A・提携分析
    Summary Selventa Inc (Selventa), formerly Genstruct Inc is a healthcare technology services provider that operates life science consulting projects. The company offers system diagnostic development services that identifies molecular mechanisms, networks and biomarkers to develop therapeutics, molecu …
  • Pakistan Oxygen Limited (LINDE):企業の財務・戦略的SWOT分析
    Pakistan Oxygen Limited (LINDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tav Havalimanlari Holding AS:戦略・SWOT・企業財務分析
    Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report Summary Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Canadian Overseas Petroleum Ltd (XOP):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Overseas Petroleum Ltd (COPL), formerly Velo Energy Inc is an oil and gas company that offers exploration and production of crude oil and natural gas properties. The company operates single well unappraised discoveries in mature basins and bringing them into production. Its projects …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆